:: Library Catalog

Cover Image

Saved in:

Bibliographic Details
Main Authors:	Isabella Badolati, Ymke de Jong, Carina Uhl, Josefin Ullberg, Marleen Joustra, Ulrika Lorentzon Fagerberg, Caroline Nilsson, Anna Asarnoj, Eva Sverremark‐Ekström
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Clinical & Experimental Allergy
Online Access:	https://onlinelibrary.wiley.com/doi/10.1111/cea.14607
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Asthma in Young Adults at High Risk for Allergies Is Traced Back to Immune and Microbiota Signatures in Early Childhood
by: Ymke A. de Jong, et al.
Published: (2026)

Oral Immunotherapy of Peanut Allergy: A Critical Role for Gut‐Associated Immunity
by: A. Kuehn, et al.
Published: (2025)

Gut Microbiota‐Derived Secondary Bile Acids Regulate Allergic Diseases
by: Lan Yang, et al.
Published: (2025)

Children Allergic to Peanut and/or Tree Nuts Are at Risk of Accidental Allergic Reactions
by: Marina Vasse, et al.
Published: (2025)

Developing a Standardised National Model of Care for Treatment of Peanut Allergy in Infants: The ADAPT Peanut Oral Immunotherapy Program
by: T. W. Brettig, et al.
Published: (2025)

Correspondence: First Peanut ( Arachis hypogaea ) Allergen Oral Immunotherapy Product Out of Sale—A Major Drawback for Food Allergy Immunotherapy?
by: S. Arasi, et al.
Published: (2026)

Oral and Gut Microbial Hubs Associated With Reaction Threshold Interact With Circulating Immune Factors in Peanut Allergy
by: Lingdi Zhang, et al.
Published: (2025)

Oral Peanut Immunotherapy With Butyrate Adjuvant ( OPIA ) in Children: A Randomised, Controlled Trial
by: Peter S. Hsu, et al.
Published: (2025)

Pragmatic Low‐Dose Oral Immunotherapy for Preschool Children With Peanut Allergy: A Randomised Controlled Trial
by: Michael O'Sullivan, et al.
Published: (2025)

Allergen‐Specific IgE is a Stronger Predictor of Remission Following Peanut Oral Immunotherapy Than Age in Children Aged 1–10 Years
by: Sarah E. Ashley, et al.
Published: (2024)

Early Oral Immunotherapy With Pasteurized Egg White in Egg‐Allergic Children Under 2 Years of Age
by: Silvia Karina Carrión Sari, et al.
Published: (2026)

Basophil Activation and Histamine Release Tests in Relation to Omalizumab Response in Peanut‐Allergic Children
by: Christian Nielsen, et al.
Published: (2025)

Cost‐Effectiveness of Allergen Immunotherapy for Allergic Rhinitis: A Systematic Review
by: Joshua Jacob, et al.
Published: (2026)

Autoclaved Peanuts Exhibit Reduced Immunoglobulin E Binding and Improved Oral Tolerability
by: Casey G. Cohen, et al.
Published: (2026)

Long‐Term Effect of Allergen Immunotherapy in Responder Local Allergic Rhinitis Patients: Symptom Control, and Prevention of Asthma and Allergic Sensitizations
by: Almudena Testera‐Montes, et al.
Published: (2025)

Long‐Term, Real‐World Effectiveness of Allergen Immunotherapy in Children and Adolescents With Allergic Rhinitis and Asthma
by: Christian Woehlk, et al.
Published: (2025)

Characterization of Human Group 9 Innate Lymphoid Cells in Response to Allergen Immunotherapy in Patients With Allergic Rhinitis
by: Ya‐Qi Peng, et al.
Published: (2025)

Making Peanuts Safer: Autoclaving as a Heat and Pressure Strategy to Increase Peanut Tolerability
by: Damian Stodulski, et al.
Published: (2026)

Adverse Effects of Dupilumab, Effects of Peanut OIT on the Gut Microbiome and Allergy Training in the United Kingdom
by: Mohamed H. Shamji, et al.
Published: (2025)

Faecalibacterium in the Gut Microbiota Predicts Tolerance Acquisition in Pediatric Hen's Egg Allergy
by: Shohei Akagawa, et al.
Published: (2025)

Prevalence Survey on Oral Allergy Syndrome in Patients With Seasonal Allergic Rhinitis in Yamanashi, Japan
by: Ayumi Shimamura, et al.
Published: (2024)

Correspondence to “Characterization of Human Group 9 Innate Lymphoid Cells in Response to Allergen Immunotherapy in Patients With Allergic Rhinitis”
by: Jiayuan Huang, et al.
Published: (2026)

Peanut Component‐Specific IgE and IgG4 Are Modulated by Sublingual Immunotherapy and Are Associated With Remission in 1–4‐Year‐Old Children
by: Neel Singh, et al.
Published: (2025)

Childhood Fractional Exhaled Nitric Oxide Predicts Incident Allergic Rhinitis in Adolescence and Young Adulthood
by: Chin‐Hung Wang, et al.
Published: (2026)

Circulating Type 2 Memory B Cell Frequency Is a Biomarker for Allergen Immunotherapy Efficacy in Patients With Allergic Rhinitis
by: Yue Ma, et al.
Published: (2026)

Adherence to Grass Pollen Allergen Immunotherapy and Allergy Medication Use in Patients With Allergic Rhinitis
by: Morten Borg, et al.
Published: (2025)

Colostrum as a Protective Factor Against Peanut Allergy: Evidence From a Birth Cohort
by: Maheshwar Bhasin, et al.
Published: (2025)

Alterations in Gut Microbiota Composition Are Related to Disease Severity and Systemic Inflammation in Patients With Chronic Urticaria
by: Han‐Ki Park, et al.
Published: (2025)

Longitudinal Follow‐Up of Gut and Salivary Microbiota in Children With Food Protein‐Induced Enterocolitis Syndrome
by: Anais Lemoine, et al.
Published: (2026)

Metabolomic pathways in food allergy
by: So‐Yeon Lee, et al.
Published: (2024)

Three‐Year Longitudinal Evaluation of Timing Effects on Subcutaneous Immunotherapy Efficacy and Safety in Allergic Rhinitis
by: Hang Li, et al.
Published: (2025)

Effects of Butyrylated High Amylose Maize Starch ( HAMSB ) as an Adjuvant for Oral Immunotherapy
by: Duan Ni, et al.
Published: (2025)

Basophil Activation Test as Biomarker of Severity and Threshold of Allergic Reactions to Cow's Milk During Oral Food Challenges
by: Holly Boyd, et al.
Published: (2025)

Efficacy and Safety of Ligelizumab in Individuals With Confirmed Peanut Allergy
by: Philippe Bégin, et al.
Published: (2026)

Codfish Oral Immunotherapy in Children Aged 2–10: Randomized Placebo‐Controlled Study
by: Agnes Sze‐yin Leung, et al.
Published: (2026)

Efficacy and Safety of Subcutaneous vs. Sublingual Immunotherapy in Allergic Rhinitis: A Systematic Review and Meta‐Analysis
by: Shambo Samrat Samajdar, et al.
Published: (2024)

Predictive Biomarkers for Sustained Unresponsiveness Following Oral Immunotherapy
by: Duan Ni, et al.
Published: (2026)

The Conversation on Oral Immunotherapy for Preschool Children Must Continue
by: Paxton Loke
Published: (2025)

NLRC4 Regulates Th2 Differentiation in Mice With Allergic Airway Inflammation Induced by House Dust Mite
by: So‐Won Pak, et al.
Published: (2025)

Oral Immunotherapy Induces Shift in lncRNA Expression Modulating Allergen‐Specific Immune Responses
by: Olivia Liong, et al.
Published: (2025)